Tadeusz Wróblewski

Tadeusz Wróblewski

Auto-generated profile, based on publicly available information

Tadeusz Wróblewski

Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
PKPiotr Kalinowski
Piotr Kalinowski
RPRafał Paluszkiewicz
Rafał Paluszkiewicz
TWTadeusz Wróblewski
Tadeusz Wróblewski
PRPiotr Remiszewski
Piotr Remiszewski
MGMariusz Grodzicki
Mariusz Grodzicki
MKMarek Krawczyk
Marek Krawczyk

1 November 2017 in Annals of Surgery
Verified
Journal Article
Closed access
PDF file
PKPiotr Kalinowski
Piotr Kalinowski
RPRafał Paluszkiewicz
Rafał Paluszkiewicz
BZBogna Ziarkiewicz-Wróblewska
Bogna Ziarkiewicz-Wróblewska
TWTadeusz Wróblewski
Tadeusz Wróblewski
PRPiotr Remiszewski
Piotr Remiszewski
MKMarek Krawczyk
Marek Krawczyk
The aim of the study was to compare the influence of sleeve gastrectomy (SG) versus Roux-en-Y gastric bypass (RYGB) on liver function in bariatric patients with non-alcoholic fatty liver disease (NAFLD) in a randomized clinical trial (NCT01806506). Rapid weight loss and malabsorption after bariatric surgery in patients with NAFLD or steatohepatitis (NASH) may impair liver function. Sixty-six morbidly obese patients randomized to SG or RYGB were included in a secondary outcome analysis. Intraoperative liver biopsies were categorized with NAFLD Activity Score (NAS) and liver function tests were done before surgery and after 1, 6 and 12 months. NASH was present in 54.5% RYGB and 51.5% SG patients (P > 0.05). At 12 months excess weight loss was 68.7 ± 19.7% after SG and 62.8 ± 18.5% after RYGB (P > 0.05). At 1 month international normalized ratio (INR) increased after RYGB (0.98 ± 0.05 vs 1.14 ± 0.11; P < 0.05) and SG (0.99 ± 0.06 vs 1.04 ± 0.06; P < 0.05), RYGB induced significantly greater increase in INR in the whole group and NASH patients than SG. After RYGB albumin decreased at 1 month (41.2 ± 2.7 vs 39.0 ± 3.2 g/L; P < 0.05). At 12 months, INR and albumin returned to baseline. At 12 months in NASH group, SG induced significant improvement in aspartate aminotransferase (32.4 ± 17.4 vs 21.5 ± 6.9U/L), alanine aminotransferase (39.9 ± 28.6U/L vs 23.8 ± 14.1U/L), gamma-glutamyl transpeptidase (34.3 ± 16.6 vs 24.5 ± 16.8U/L), and lactate dehydrogenase (510.8 ± 33 vs 292.4 ± 29). Variables predictive of INR change after 1 month included operation type, NAS ≥ 5, bilirubin, body mass index, hemoglobin A1C, and dyslipidemia. Patients with NASH undergoing RYGB are more susceptible to early transient deterioration of liver function than after SG.

20 December 2012 in Videosurgery and Other Miniinvasive Techniques
Verified
Journal Article
Open access
RPRafał Paluszkiewicz
Rafał Paluszkiewicz
PKPiotr Kalinowski
Piotr Kalinowski
TWTadeusz Wróblewski
Tadeusz Wróblewski
ZBZbigniew Bartoszewicz
Zbigniew Bartoszewicz
JBJanina Białobrzeska-Paluszkiewicz
Janina Białobrzeska-Paluszkiewicz
MKMarek Krawczyk
Marek Krawczyk
Introduction: Roux-en-Y gastric bypass (RYGB) is considered the gold standard bariatric procedure with documented safety and effectiveness. Laparoscopic sleeve gastrectomy (LSG) is a newer procedure being done with increasing frequency. Randomized comparisons of LSG and other bariatric...

31 December 2003
Verified
Journal Article
Closed access
PMPiotr Malkowski
Piotr Malkowski
JPJacek Pawlak
Jacek Pawlak
BMBogdan Michalowicz
Bogdan Michalowicz
JSJerzy Szczerban
Jerzy Szczerban
TWTadeusz Wroblewski
Tadeusz Wroblewski
MKMarek Krawczyk
Marek Krawczyk

1 January 2012 in Polish Journal of Surgery
Verified
Journal Article
Open access
PDF file
MKMarek Krawczyk
Marek Krawczyk
MGMichał Grąt
Michał Grąt
KBKrzysztof Barski
Krzysztof Barski
JLJoanna Ligocka
Joanna Ligocka
AAArkadiusz Antczak
Arkadiusz Antczak
JSJerzy Szczerbań
Jerzy Szczerbań
The aim of the study was to analyze indications and results of the first one thousand liver transplantations at Chair and Clinic of General, Transplantation and Liver Surgery, Medical University of Warsaw. Material and methods. Data from 1000 transplantations (944 patients) performed at Chair and Clinic of General, Transplantation and Liver Surgery between 1994 and 2011 were analyzed retrospectively. These included 943 first transplantations and 55 retransplantations and 2 re-retransplantations. Frequency of particular indications for first transplantation and retransplantations was established. Perioperative mortality was defined as death within 30 days after the transplantation. Kaplan-Meier survival analysis was used to estimate 5-year patient and graft survival. Results. The most common indications for first transplantation included: liver failure caused by hepatitis C infection (27.8%) and hepatitis B infection (18%) and alcoholic liver disease (17.7%). Early (< 6 months) and late (> 6 months) retransplantations were dominated by hepatic artery thrombosis (54.3%) and recurrence of the underlying disease (45%). Perioperative mortality rate was 8.9% for first transplantations and 34.5% for retransplantations. Five-year patient and graft survival rate was 74.3% and 71%, respectively, after first transplantations and 54.7% and 52.9%, respectively, after retransplantations. Conclusions. Development of liver transplantation program provided more than 1000 transplantations and excellent long-term results. Liver failure caused by hepatitis C and B infections remains the most common cause of liver transplantation and structure of other indications is consistent with European data.

14 September 2000 in Transplantation Proceedings
Verified
Journal Article
Closed access
JPJ Pawlak
J Pawlak
TWT Wróblewski
T Wróblewski
PMPiotr Malkowski
Piotr Malkowski
PNP Nyckowski
P Nyckowski
KZK Zieniewicz
K Zieniewicz
AKA Karwowski
A Karwowski